• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Pediatrics

Gender conformity influences use of laxatives and muscle-building products

bySara RubinandCordelia Ross
July 14, 2016
in Pediatrics, Psychiatry
Reading Time: 3 mins read
Gender conformity influences use of laxatives and muscle-building products
Share on FacebookShare on Twitter

1. Greater gender conformity in childhood was associated with increased use of laxatives in females and muscle-building products in males, with the prevalence of such behaviors increasing with age.

2. Approximately 20% of sexual minority females (e.g., bisexual or lesbian) aged 23 to 25 years reported past-year laxative use for weight management.

Evidence Rating Level: 2 (Good)

Study Rundown: Using laxatives to lose weight or taking muscle-building products (e.g., creatine, steroids) to bulk up may lead to dependence and negative health outcomes. The use of such substances is known to vary along gender lines and sexual orientation, with females (in particular, minority orientation females) more likely to take laxatives and males more likely to use muscle-building products. To better understand these associations and investigate a potential link to gender conformity, authors surveyed the behaviors of adolescents and young adults from the Growing Up Today Study (GUTS). With regard to laxatives, sexual minority females were found to have approximately double the odds of use compared to their heterosexual counterparts. Further, regardless of sexual orientation, increased childhood femininity was associated with greater laxative abuse. The results for males and muscle-building products differed—while increased childhood masculinity was associated with use, the odds did not vary with sexual orientation. Limitations of this study included its reliance on retrospective data assessing childhood and not current gender conformity, lack of generalizability due to a homogenous sample (>90% Caucasian), and inability to account for potential confounding factors such as current occupation, hobbies (e.g., sports), and autoimmune disease status. Nevertheless, the results suggest that gender conforming children and sexual minority girls may be at greater risk of taking laxatives (females) or muscle-building products (males) in young adulthood, thus identifying at-risk populations that may benefit from earlier clinical surveillance.

Click to read the study, published today in Pediatrics

Relevant Reading: Sexual orientation, weight concerns, and eating-disordered behaviors in adolescent girls and boys

RELATED REPORTS

An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain

Daraxonrasib extends survival in metastatic pancreatic cancer

Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being

Jerel P. Calzo, PhD, MPH and co-authors, talk to 2 Minute Medicine: Division of Adolescent/Young Adult Medicine, Boston Children’s Hospital, Boston, Massachusetts.

“Results from this study suggest that social pressure to conform to gender norms during adolescence, including those concerning appearance, are linked to harmful weight management and muscle-building behaviors among heterosexual and sexual minority youth alike. Clinicians should be aware that highly gender conforming girls may be at risk for abusing laxatives in adolescence, and highly gender conforming boys may be at risk for abusing muscle-building products (e.g., creatine, steroids) in adolescence.”

In-Depth [longitudinal study]: Survey respondents included a subset of adolescents and young adults from the GUTS, all of whom are children of women in the Nurses’ Health Study II. Data was analyzed from questionnaires completed from 1999 through 2007 (N = 14 134 sexual orientation, N = 10 904 childhood gender conformity, N = 12 965 laxative use, and N = 13 629 muscle-building products use). Sexual orientation, laxative use, and muscle-building product use, although surveyed in multi-answer format, were collapsed to dichotomous variables (e.g., “sexual minority” encompassed “mostly heterosexual,” “bisexual,” “mostly homosexual,” and “completely homosexual”). To assess gender conformity, gender expression during childhood was measured. Analysis was based on a repeated-measures design. Only laxative use in females and muscle-building product use in males were studied due to the low prevalence in cross-comparisons. In females, significantly greater odds of any past-year laxative use were found with advancing age (OR = 14.96 oldest (23 to 25 years) vs. youngest (13 to 15 years), p < 0.001), sexual minority status (OR = 2.10, p < 0.001), and childhood femininity (OR = 1.51 most vs. least, p < 0.01). As for males, advancing age (OR = 3.36 oldest vs. youngest, p < 0.001) and childhood masculinity (OR = 1.79 most vs. least, p < 0.001), but not minority sexual orientation, were associated with greater odds of muscle-building product use. Sexual orientation did not significantly modify the associations between childhood gender conformity and laxative use in females and muscle-building product use in males.

Image: CC

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Previous Post

Catheter ablation more effective than antiarrythmic escalation for ventricular tachycardia: The VANISH trial

Next Post

No mortality difference between early and delayed renal replacement therapy: The AKIKI trial

RelatedReports

Chronic Disease

An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain

September 17, 2026
Oncology

Daraxonrasib extends survival in metastatic pancreatic cancer

September 17, 2026
Artificial Intelligence

Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being

September 16, 2026
Emergency

A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality

September 16, 2026
Next Post
Corticosteroids improve outcomes in treatment of community-acquired pneumonia

No mortality difference between early and delayed renal replacement therapy: The AKIKI trial

Survivors of adult-onset cancers associated with increased incidence of cardiovascular disease

Olanzapine may reduce nausea symptoms for patients on chemotherapy

Adverse pregnancy outcomes associated with thrombophilias [Classics Series]

The BHAT: Propranolol after acute myocardial infarction [Classics Series]

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.